Suppr超能文献

特定病因精算生存分析:一种报告局限性前列腺癌男性患者生存数据的有用方法。

Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.

作者信息

Lepor H, Kimball A W, Walsh P C

机构信息

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

J Urol. 1989 Jan;141(1):82-4. doi: 10.1016/s0022-5347(17)40596-9.

Abstract

The primary objective of this retrospective 15-year survival analysis of 57 men with clinical stage B1 carcinoma of the prostate undergoing radical prostatectomy between 1951 and 1963 is to compute the cause-specific curve for these men and argue why it is a useful method to report survival data in men with clinically localized prostatic cancer. Historically, survival following radical prostatectomy and radiotherapy has been reported using all cause survival analysis. Cause-specific survival focuses on the impact of a disease process on survival, since men dying of causes unrelated to carcinoma of the prostate are considered lost to followup as of date of death of such unrelated causes. Cause-specific survival analysis reduces the impact of age, medical condition and other risk factors on survival rates. The cause-specific 15-year actuarial survival rate in our patients was 86 per cent. The 95 per cent confidence interval for this 15-year survival rate was 76.9 to 90.1 per cent. Based upon this series of patients with clinical stage B1 carcinoma of the prostate who undergo radical prostatectomy one may state that the chance of death of carcinoma of the prostate within 15 years of surgery averages 14 +/- 5 per cent. The cause-specific survival curve reached a plateau at 10 years, indicating that most men who survive 10 years are cured of the disease. With the Cox model regression analysis, mortality in this series was related positively to age at operation when the outcome variable was death of all causes (p equals 0.003) but it was unrelated to age when the outcome variable was prostate cancer mortality (p equals 0.85). Cause-specific survival rates are a more precise indicator of the impact of a therapeutic modality on survival and, therefore, they are useful to report survival data in men with localized carcinoma of the prostate and other disease when death from competing causes is an important consideration.

摘要

本项回顾性研究对1951年至1963年间接受根治性前列腺切除术的57例临床B1期前列腺癌男性患者进行了15年生存分析,其主要目的是计算这些患者的病因特异性生存曲线,并论证为何这是报告临床局限性前列腺癌男性患者生存数据的一种有用方法。从历史上看,根治性前列腺切除术后和放疗后的生存情况一直采用全因生存分析进行报告。病因特异性生存关注疾病进程对生存的影响,因为死于与前列腺癌无关原因的男性自因此类无关原因死亡之日起被视为失访。病因特异性生存分析降低了年龄、医疗状况和其他风险因素对生存率的影响。我们患者的病因特异性15年精算生存率为86%。该15年生存率的95%置信区间为76.9%至90.1%。基于这一系列接受根治性前列腺切除术的临床B1期前列腺癌患者,可以说前列腺癌在手术后15年内的死亡几率平均为14±5%。病因特异性生存曲线在10年时达到平台期,表明大多数存活10年的男性已治愈该疾病。通过Cox模型回归分析,当结局变量为全因死亡时,本系列患者的死亡率与手术时年龄呈正相关(p = 0.003),但当结局变量为前列腺癌死亡率时,死亡率与年龄无关(p = 0.85)。病因特异性生存率是一种更精确的指标,可用于衡量治疗方式对生存的影响,因此,在报告局限性前列腺癌及其他疾病男性患者的生存数据时,如果竞争原因导致的死亡是一个重要考虑因素,它们是有用的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验